JANUS HENDERSON GROUP PLC - Jan 31, 2025 Form SCHEDULE 13G Schedule Report for BRIGHT MINDS BIOSCIENCES INC. (DRUG)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
BRIGHT MINDS BIOSCIENCES INC. Common Stock
Symbol
DRUG
Shares outstanding
6.94M shares
Disclosed Ownership
805K shares
Ownership
11.6%
Form type
SCHEDULE 13G
Date filed
2/7/2025, 10:49 AM
Date of event
Jan 31, 2025
Next filing
Apr 7, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 11.6% 805K 0 805K Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 10.4% 720K 0 720K Kristin Mariani Head of North America Compliance, CCO